- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05847309
Early vs Delayed Extubation After Endovascular Treatment for Acute Ischemic Stroke (EDESTROKE)
Optimal Ventilation Time After Endovascular Treatment Under General Anesthesia for Acute Ischemic Stroke. A Prospective, Randomized Comparison Between Early vs Delayed Extubation
Although older studies, most of them retrospective in design, advocated sedation over general anesthesia during endovascular treatment for acute ischemic stroke, a recent meta-analysis and randomized studies have shown that general anesthesia is associated with better functional status at 3 months compared with local anesthesia and sedation. In our center, most procedures are performed under general anesthesia, and once the procedure is complete, the patient is transferred intubated and sedated to the ICU. If the patient is hemodynamically and respiratory stable, the patient will be extubated, and will be discharged to the Neurology hospitalization floor.
Several factors have been described that may influence the evolution and functional status at three months of patients who have suffered a stroke and have received endovascular treatment, such as the time between the onset of symptoms and admission to the ward for performing the procedure, the use of general anesthesia compared to sedation and local anesthesia, adequate control of blood pressure, the size of the cerebral infarct, or a worse neurological examination at the time of the procedure. In turn, several factors have been described that may influence the success of extubation in a patient who has suffered an acute ischemic stroke and who has required orotracheal intubation, such as the absence of dysarthria, the size of the infarct, the location of the infarction, the NIHSS (National Institutes of health Stroke Scale) or neurological status prior to orotracheal intubation. The investigators do not know, however, whether the time of mechanical ventilation can influence the evolution and functional status at three months of patients who have suffered a stroke and have received endovascular treatment under general anesthesia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
A Coruña
-
Santiago de Compostela, A Coruña, Spain, 15866
- University Clinical Hospital of Santiago de Compostela
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult (age ≥ 18 years)
- Acute ischemic stroke due to large intracranial vessel occlusion demonstrated on CT-angiography in the following anterior circulation locations (occlusion of the internal carotid artery and/or middle cerebral artery in segments M1, M2, M3) within 24 hours of symptom onset.
- Patients admitted with a NIHSS neurological status ≥ 6.
- Patients who received endovascular treatment under general anesthesia (intubated in the interventional radiology room) with satisfactory reperfusion (TICI 2b-2c-3).
- Patients admitted in the intensive care unit (ICU) with mechanical ventilation.
- Written informed consent from the patient or proxy (if present) before inclusion or once possible when patient has been included in a context of emergency.
Exclusion Criteria:
- Patients who have not been intubated in the interventional radiology room.
- Pregnancy
- Patients who suffer bronchial aspiration prior to the endovascular procedure or during intubation.
- Patients who underwent the procedure under local anesthesia and sedation.
- Patients with functional neurological status, prior to the ischemic stroke, measured with the modified Rankin scale (mRS) of value: 3-6.
- Patients with vascular involvement of the posterior cerebral circulation, or intracranial haemorrhage associated with stroke.
- Patients who do not sign the informed consent by themselves or their relatives.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Early extubation
Patients randomized to early extubation, will be extubated < 6 hours after endovascular treatment under general anesthesia.
|
Patients randomized to early extubation, will be extubated < 6 hours after endovascular treatment under general anesthesia.
|
|
Experimental: Delayed extubation
Patients randomized to delayed extubation, will be extubated 6-12 hours after endovascular treatment under general anesthesia.
|
Patients randomized to delayed extubation, will be extubated 6-12 hours after endovascular treatment under general anesthesia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Ranking Scale (mRS)
Time Frame: 90 days
|
Comparison of independent functional outcome as measured by the percentage of patients with a 0 to 2 on the modified Rankin Scale (mRS) at 90 days assessed by study personal blinded to the treatment (early vs delayed extubation) The scale of mRS is 0 to 6. The best neurological outcome is the mRS with 0, indicating no any symptom left, and a good neurological outcome is agreed with a mRS 0 to 2. mRS of 6 is the worst, indicating death. mRS will be evaluated by outcome assessor who is blinded to the group |
90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NIHSS (National Institutes of Health Stroke Scale)
Time Frame: Approximately 1-15 days post procedure
|
Change in NIHSS score on day 1 and at the time of hospital discharge compared to admission to hospital. The NIHSS is composed of 11 items, each of which scores a specific ability between a 0 and 4. For each item, a score of 0 typically indicates normal function in that specific ability, while a higher score is indicative of some level of impairment.The individual scores from each item are summed in order to calculate a patient's total NIHSS score. The maximum possible score is 42, with the minimum score being a 0. NIHSS score of 42 is the worst score (severe stroke), NIHSS score of 0 is "No stroke symptoms". 0 No stroke symptoms 1-4 Minor stroke 5-15 Moderate stroke 16-20 Moderate to severe stroke 21-42 Severe stroke |
Approximately 1-15 days post procedure
|
|
Modified Ranking Scale (mRS)
Time Frame: Approximately 3-15 days post procedure
|
Comparison of independent functional outcome as measured by the percentage of patients with a 0 to 2 on the modified Rankin Scale (mRS) at the time of hospital discharge assessed by study personal blinded to the treatment (early vs delayed extubation) The scale of mRS is 0 to 6. The best neurological outcome is the mRS with 0, indicating no any symptom left, and a good neurological outcome is agreed with a mRS 0 to 2. mRS of 6 is the worst, indicating death. mRS will be evaluated by outcome assessor who is blinded to the group |
Approximately 3-15 days post procedure
|
|
Hospital length of stay
Time Frame: Approximately 3-15 days post procedure
|
Duration in days of hospital stay
|
Approximately 3-15 days post procedure
|
|
Intensive Care Unit length of stay
Time Frame: Approximately 1-15 days post procedure
|
Duration in days of ICU stay
|
Approximately 1-15 days post procedure
|
|
Patients extubated in the assigned group
Time Frame: Post procedure within 24 hours
|
Percentage of patients who can be extubated in the assigned group
|
Post procedure within 24 hours
|
|
Number of patients with ICU complications
Time Frame: Approximately 1-10 days post procedure
|
Complications: Pneumonia, sepsis, bacteraemia, tracheostomy, bronchial aspiration, others
|
Approximately 1-10 days post procedure
|
|
Number of patients with complications associated with mechanical ventilation
Time Frame: Approximately 1-10 days post procedure
|
Complications: Pneumonia, pneumothorax, respiratory distress, others
|
Approximately 1-10 days post procedure
|
|
Number of patients with Hospital complications
Time Frame: Approximately 1-15 days post procedure
|
Complications: Pneumonia, sepsis, others
|
Approximately 1-15 days post procedure
|
Collaborators and Investigators
Investigators
- Principal Investigator: Manuel Taboada, Ph.D., Clinical University Hospital of Santiago de Compostela
- Principal Investigator: Manuel Rodríguez, M.D., Clinical University Hospital of Santiago de Compostela
Publications and helpful links
General Publications
- Coplin WM, Pierson DJ, Cooley KD, Newell DW, Rubenfeld GD. Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med. 2000 May;161(5):1530-6. doi: 10.1164/ajrccm.161.5.9905102.
- Nikoubashman O, Schurmann K, Probst T, Muller M, Alt JP, Othman AE, Tauber S, Wiesmann M, Reich A. Clinical Impact of Ventilation Duration in Patients with Stroke Undergoing Interventional Treatment under General Anesthesia: The Shorter the Better? AJNR Am J Neuroradiol. 2016 Jun;37(6):1074-9. doi: 10.3174/ajnr.A4680. Epub 2016 Jan 28.
- Fandler-Hofler S, Heschl S, Kneihsl M, Arguelles-Delgado P, Niederkorn K, Pichler A, Deutschmann H, Fazekas F, Berghold A, Enzinger C, Gattringer T. Ventilation time and prognosis after stroke thrombectomy: the shorter, the better! Eur J Neurol. 2020 May;27(5):849-855. doi: 10.1111/ene.14178. Epub 2020 Mar 17.
- Taboada M, Estany-Gestal A, Fernandez J, Barreiro L, Williams K, Rodriguez-Yanez M, Otero P, Naveira A, Caruezo V, Veiras S, San Luis E, Dos Santos L, Diaz-Vieito M, Arias-Rivas S, Santamaria-Cadavid M, Rodriguez-Castro E, Vazquez F, Blanco M, Mosquera A, Castineiras JA, Muniategui I, Ferreiroa E, Carinena A, Tubio A, Campana O, Selas S, Aneiros F, Martinez A, Eiras M, Costa J, Prieto JM, Alvarez J. Effect of early vs. delayed extubation on functional outcome among patients with acute ischemic stroke treated with endovascular thrombectomy under general anesthesia: the prospective, randomized controlled EDESTROKE trial study protocol. Trials. 2024 Jun 4;25(1):357. doi: 10.1186/s13063-024-08181-y.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EDESTROKE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Ischemic Stroke
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
University of CalgaryThe George Institute for Global Health, AustraliaRecruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
University of MiamiNo longer availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
Southwest Hospital, ChinaRecruitingAcute Ischemic Stroke PatientsChina
-
Hyogo Medical UniversityRecruitingAcute Ischemic Stroke | Endovascular Therapy | Acute Ischemic Stroke (AIS) Related to a Distal OcclusionJapan
-
NeurotechnikaSamara State Medical University; Samara Regional Clinical Hospital V.D. SeredavinRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Acute | Stroke, Acute, Ischemic | Stroke with HemiparesisRussian Federation
-
Xiangya Hospital of Central South UniversityNot yet recruitingMild Disabling Acute Ischemic Stroke
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
Dongzhimen Hospital, BeijingThe Second Hospital of Hebei Medical University; Peking University Third Hospital and other collaboratorsRecruitingStroke, Ischemic | Stroke, Acute | Acute Ischemic StrokeChina
-
Beijing Tiantan HospitalCompletedIschemic Stroke, AcuteChina
Clinical Trials on Early extubation
-
University of LiegeRecruiting
-
Fondation Hôpital Saint-JosephNot yet recruitingHypoxemia | Extubation | Postoperative Respiratory ComplicationFrance
-
Hospital Donación Francisco SantojanniUnknown
-
Hospital Donación Francisco SantojanniMatías Bertozzi; Marco Bezzi; Silvina Borello; Daniela Castro; Victoria Di Giorgio; Mariana Aguirre and other collaboratorsTerminatedMechanical Ventilation Complication | Weaning FailureArgentina
-
Women and Infants Hospital of Rhode IslandCompletedBronchopulmonary DysplasiaUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedHeart Failure | Central Nervous System Diseases | Shock | Acute Respiratory Failure | Acute PoisoningFrance
-
First Affiliated Hospital, Sun Yat-Sen UniversityCompletedMyasthenia Gravis Associated With Thymoma
-
Medipol UniversityCompletedHypoxia | Anesthesia, General | Extubation | Atelectasis | Postoperative Respiratory ComplicationTurkey (Türkiye)
-
Peking University First HospitalRecruitingPostoperative Complications | Airway Extubation | Robotic Surgical Procedures | Anesthesia Recovery Period | Operating RoomsChina
-
University of SaskatchewanTerminatedIntubation, IntratrachealCanada